PDL BIOPHARMA, INC. as Issuer AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee SUPPLEMENTAL INDENTURE Dated as of November 22, 2016Supplemental Indenture • November 28th, 2016 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 28th, 2016 Company Industry JurisdictionSUPPLEMENTAL INDENTURE, dated as of November 22, 2016 (this “Supplemental Indenture”), between PDL BioPharma, Inc., a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A, as trustee (the “Trustee”) under the Indenture dated as of November 22, 2016, between the Company and the Trustee (as amended or supplemented from time to time in accordance with the terms thereof, the “Base Indenture”).